SURI - Simplify Propel Opportunities ETF (USD) (US82889N6242)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Hepsini seç Hepsini sıfırla

Kaydet Kapat

(%)

US82889N6242

SURI ISIN

Borsa Yatırım Fonları (BYF)

Fon türü

Simplify Asset Management

Sağlayıcı

Hisse başına net varlık değeri

07.02.2023

Başlangıç tarihi

4 yılda ... kez

Temettü ödemeleri

CEOJLS

CFI

SURI

Menkul değer sembolü

Formed

Status

Equity

Yatırım kategorisi

Healthcare

Sektör

Global

Coğrafya

No benchmark

Karşılaştırma ölçütü (benchmark)

2.54 %

Toplam Maliyet Oranı

Physical

Replikasyon yöntemi

70,64 milyon USD

Fonun toplam varlıkları | 02.04.2026

70,64 milyon USD

Hisse senedi sınıfı varlıkları | 02.04.2026

Hayır

UCITS

Getiri on 02.04.2026, NYSE Arca

YTD

-5,64 %
1M

-8,47 %
3M

-5,64 %
6M

3 %
1Y

17,47 %
3Y

25,44 %
5Y

-
10Y

-

Gelir ödemeleri dikkate alınarak borsadaki fiyat üzerinden

Şu tarihe ilişkin son veriler

Karşılaştırmak için öğe ekleyin

Kotasyonlar (SURI)

En kapsamlı veri tabanını keşfedin

1 000 000

tahvi̇ller

80 234

hisse senetleri

167 970

ETF & Funds

80 000

endeksler

Portföyünüzü en etkili şekilde takip edin

Tahvi̇l arama
Watchlist
Excel Eklentisi

Erişim sağlamak

Fiyat dinamiklerindeki değişimler

Fund profile

The Simplify Propel Opportunities ETF is an actively managed ETF that seeks long-term capital appreciation by investing in a portfolio comprised primarily of global biotech, pharma, health care technology, and life science companies

SURI profile

The Simplify Propel Opportunities ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The Simplify Asset Management fund’s base currency is USD and the share class was registered 07.02.2023 with unique ISIN - US82889N6242. Main exchange is NYSE Arca and ticker symbol is SURI. The total expense ratio is 2.54%. The Simplify Propel Opportunities ETF (USD) pays dividends 4 time(s) per year.

Yapı SURI on 02.04.2026

Excel'de yapıyı indir

Menkul kıymet	Değer
PLAINS GP HLDGS L P	43,34%
ACHIEVE LIFE SCIENCES INC USD 0.001	5,42%
PHATHOM PHARMACEUTICALS USD 0.0001	4,21%
DELCATH SYS INC USD 0.01	3,56%
ABEONA THERAPEUTICS INC USD 0.01	3,41%
CELLDEX THERAPEUTICS INC USD 0.001	3,03%
MILESTONE PHARMACEUTICALS INC NPV	2,94%
OCULIS HOLDING AG CHF 0.01	2,51%
LEONABIO INC USD 0.0001	2,4%
CORCEPT THERAPEUTICS INC USD 0.001	2,27%
KYVERNA THERAPEUTICS IN USD 0.00001	2,17%
INVENTIVA SA NPV ADR	1,77%
Cash	1,67%
VIRIDIAN THERAPEUTICS INC USD 0.01	1,5%
AQUESTIVE THERAPEUTICS IN USD 0.001	1,37%
VOR BIOPHARMA INC USD 0.0001	1,37%
ORCHESTRA BIOMED HLDGS I USD 0.0001	1,33%
COMPASS PATHWAYS PLC USD 0.008 ADR	1,3%
ZEVRA THERAPEUTICS INC USD 0.0001	1,28%
Telesat, 5.625% 6dec2026, USD	1,18%
TREVI THERAPEUTICS INC USD 0.001	1,11%
OCULAR THERAPEUTIX INC USD 0.0001	1,08%
UPSTREAM BIO INC USD 0.001	1,05%
SAB BIOTHERAPEUTICS INC USD 0.0001	1,03%
EYEPOINT INC	1,02%
4D MOLECULAR THERAPEUTIC USD 0.0001	0,95%
PALISADE BIO INC USD 0.01	0,94%
ZEALAND PHARMA A/S DKK 1.0	0,76%
IMMUNIC INC USD 0.0001	0,72%
KALARIS THERAPEUTICS INC USD 0.0001	0,72%
COHERUS ONCOLOGY INC USD 0.0001	0,62%
AKERO THERAPEUTICS INC CVR	0,6%
CORVUS PHARMACEUTICALS I USD 0.0001	0,42%
OVID THERAPEUTICS INC USD 0.001	0,41%
ACHIEVE LIFE SCIENCES I WTS 30JUN30	0,31%
ARTIVA BIOTHERAPEUTICS I USD 0.0001	0,22%
Chinook Therapeutics, ord.	0%
EIGER BIOPHARMACEUTICALS USD 0.0001	0%
WTS - MILESTONE PHARMACEUTICALS INC SERIES A	0%
WTS - MILESTONE PHARMACEUTICALS INC SERIES B	0%
WTS - TENAYA THERAPEUTICS INC	0%
JASPER THERAPEUTIC WTS	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series J	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series H	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series K	0%
WTS - QUOIN PHARMACEUTICALS LTD - Series I	0%

Tümünü göster Gizle

Other - %

Bu sağlayıcıdan diğer ETF ve Fonlar

Benzer ETF ve Fonlar

{{ item.etf.ttl }}

{{ item.nav_usd }} milyon
Net Varlık Değeri

{{ item.expense_ratio }}
Toplam Maliyet Oranı